Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma
- Ok, Chi Young
- Chen, Jiayu
- Xu-Monette, Zijun Y
- Tzankov, Alexandar
- Manyam, Ganiraju C
- Li, Ling
- Visco, Carlo
- Montes-Moreno, Santiago
- Dybkær, Karen
- Chiu, April
- Orazi, Attilio
- Zu, Youli
- Bhagat, Govind
- Richards, Kristy L
- Hsi, Eric D
- Choi, William W L
- van Krieken, J Han
- Huh, Jooryung
- Zhao, Xiaoying
- Ponzoni, Maurilio
- Ferreri, Andrés J M
- Bertoni, Francesco
- Farnen, John P
- Møller, Michael B
- Piris, Miguel A
- Winter, Jane N
- Medeiros, L Jeffrey
- Young, Ken H
Publication date
January 2014
DOI Publisher
American Association for Cancer Research (AACR)Abstract
Activated signal transducer and activator of transcription 3 (STAT3) regulates tumor growth, invasion, cell proliferation, angiogenesis, immune response, and survival. Data regarding expression of phosphorylated (activated) STAT3 in diffuse large B-cell lymphoma (DLBCL) and the impact of phosphorylated STAT3 (pSTAT3) on prognosis are limited
Add to ORKG